MorphaBond – FAQ

MorphaBond (morphine sulfate) is a pain management opioid drug found in the form of extended-release tablets. It is used for the management of pain that requires daily, around-the-clock, and long-term opioid treatment for which alternative options have not worked.

Due to the increase in abuse of opioid drugs in the United States, the developer of MorphaBond (Daiichi Sankyo) created the formulation to include a feature called SentryBond which is an abuse-deterring set of inactive ingredients that make adulteration of the drug more difficult.

As with most opioids that are abused, the method is via first crushing the tablet then ingesting the drug by inhalation or injection. With MorphaBond, either method becomes less likely as the introduction of water leads to a formation of a viscous material that cannot be passed through a needle or easily inhaled. Despite this, other forms of abuse are still possible. It is intended for MorphaBond to be taken every 12 hours and individuals may choose to take it more frequently if their pain is not being alleviated. Additionally, users can readily take more of the drug at once for the same reason. Either way, this can lead to an overdose or the formation of an addiction to MorphaBond as the body develops a tolerance to the opioid.

MorphaBond should not be discontinued suddenly as withdrawal symptoms can occur. The effects of sudden withdrawal can include muscle pain, pupil dilation, excessive perspiration, excessive tearing of eyes, irritability, anxiety, insomnia, increased heart rate, diarrhea, nausea, rapid respiration, and increased blood pressure.

If you or somebody you know has become reliant on using MorphaBond, you may have questions about what can be done. To learn more, check out our frequently asked questions about MorphaBond or contact a representative at The Recovery Village to learn about options for recovery.